COMIRNATY ORIGINAL/OMICRON BA.1
COMIRNATY ORIGINAL/OMICRON BA.1
Discontinued
DIN Number
02532018
Drug Class
Human
Market Date
N/A
Company
HC
BioNTech Manufacturing GmbH
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02532018
AIG Number0264161001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D
A
ATC Code
J07BN01 COVID-19, RNA-BASED VACCINE
Product Specifications
Dosage FormSuspension
Route of AdministrationIntramuscular
AHFS Classification80:12.00
Health Canada Classification
ACTIVE INGREDIENTS (2)
RILTOZINAMERANActive
Strength: 15 MCG / 0.3 ML
Monograph: RILTOZINAMERAN
TOZINAMERANActive
Strength: 15 MCG / 0.3 ML
Monograph: TOZINAMERAN